THURMAN RANDY H 4/A
4/A · Outlook Therapeutics, Inc. · Filed Sep 17, 2020
Insider Transaction Report
Form 4/AAmended
THURMAN RANDY H
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-07-17+154,555→ 154,555 totalExercise: $1.58Exp: 2030-07-17→ Common Stock (154,555 underlying)
Footnotes (1)
- [F1]The options were granted under the Issuer's 2015 Equity Incentive Plan (the "2015 Plan") and shall vest in full on July 17, 2021, subject to the Reporting Person providing continuous service to the Issuer on such date and subject to acceleration upon a Change in Control as defined in the 2015 Plan, subject to the Reporting Person providing continuous service to the Issuer through such event.